132 related articles for article (PubMed ID: 33243135)
1. Contribution of Rs780094 and Rs1260326 Polymorphisms in GCKR Gene to Non-alcoholic Fatty Liver Disease: A Meta-Analysis Involving 26,552 Participants.
Li J; Zhao Y; Zhang H; Hua W; Jiao W; Du X; Rui J; Li S; Teng H; Shi B; Yang X; Zhu L
Endocr Metab Immune Disord Drug Targets; 2021; 21(9):1696-1708. PubMed ID: 33243135
[TBL] [Abstract][Full Text] [Related]
2. Association of glucokinase regulatory gene polymorphisms with risk and severity of non-alcoholic fatty liver disease: an interaction study with adiponutrin gene.
Tan HL; Zain SM; Mohamed R; Rampal S; Chin KF; Basu RC; Cheah PL; Mahadeva S; Mohamed Z
J Gastroenterol; 2014 Jun; 49(6):1056-64. PubMed ID: 23800943
[TBL] [Abstract][Full Text] [Related]
3. Common variant in the glucokinase regulatory gene rs780094 and risk of nonalcoholic fatty liver disease: a meta-analysis.
Zain SM; Mohamed Z; Mohamed R
J Gastroenterol Hepatol; 2015 Jan; 30(1):21-7. PubMed ID: 25167786
[TBL] [Abstract][Full Text] [Related]
4. Genetic polymorphisms associated with nonalcoholic fatty liver disease in Uyghur population: a case-control study and meta-analysis.
Cai W; Weng DH; Yan P; Lin YT; Dong ZH; Mailamuguli ; Yao H
Lipids Health Dis; 2019 Jan; 18(1):14. PubMed ID: 30646922
[TBL] [Abstract][Full Text] [Related]
5. Association of GCKR Gene Polymorphisms with the Risk of Nonalcoholic Fatty Liver Disease and Coronary Artery Disease in a Chinese Northern Han Population.
Gao H; Liu S; Zhao Z; Yu X; Liu Q; Xin Y; Xuan S
J Clin Transl Hepatol; 2019 Dec; 7(4):297-303. PubMed ID: 31915598
[No Abstract] [Full Text] [Related]
6. The association between rs1260326 with the risk of NAFLD and the mediation effect of triglyceride on NAFLD in the elderly Chinese Han population.
Yuan F; Gu Z; Bi Y; Yuan R; Niu W; Ren D; Zhang L; He G; Liu BC
Aging (Albany NY); 2022 Mar; 14(6):2736-2747. PubMed ID: 35333773
[TBL] [Abstract][Full Text] [Related]
7. Waist circumference mediates the association between rs1260326 in GCKR gene and the odds of lean NAFLD.
Wu N; Li J; Zhang J; Yuan F; Yu N; Zhang F; Li D; Wang J; Zhang L; Shi Y; He G; Ji G; Liu B
Sci Rep; 2023 Apr; 13(1):6488. PubMed ID: 37081070
[TBL] [Abstract][Full Text] [Related]
8. Glucokinase regulatory protein gene polymorphism affects liver fibrosis in non-alcoholic fatty liver disease.
Petta S; Miele L; Bugianesi E; Cammà C; Rosso C; Boccia S; Cabibi D; Di Marco V; Grimaudo S; Grieco A; Pipitone RM; Marchesini G; Craxì A
PLoS One; 2014; 9(2):e87523. PubMed ID: 24498332
[TBL] [Abstract][Full Text] [Related]
9. Genetic determinants of steatosis and fibrosis progression in paediatric non-alcoholic fatty liver disease.
Hudert CA; Selinski S; Rudolph B; Bläker H; Loddenkemper C; Thielhorn R; Berndt N; Golka K; Cadenas C; Reinders J; Henning S; Bufler P; Jansen PLM; Holzhütter HG; Meierhofer D; Hengstler JG; Wiegand S
Liver Int; 2019 Mar; 39(3):540-556. PubMed ID: 30444569
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of
Nisar T; Arshad K; Abbas Z; Khan MA; Safdar S; Shaikh RS; Saeed A
J Obes; 2023; 2023():6661858. PubMed ID: 37829557
[TBL] [Abstract][Full Text] [Related]
11. Association of polymorphisms in GCKR and TRIB1 with nonalcoholic fatty liver disease and metabolic syndrome traits.
Kitamoto A; Kitamoto T; Nakamura T; Ogawa Y; Yoneda M; Hyogo H; Ochi H; Mizusawa S; Ueno T; Nakao K; Sekine A; Chayama K; Nakajima A; Hotta K
Endocr J; 2014; 61(7):683-9. PubMed ID: 24785259
[TBL] [Abstract][Full Text] [Related]
12. Genetic variation in the GCKR gene is associated with non-alcoholic fatty liver disease in Chinese people.
Yang Z; Wen J; Tao X; Lu B; Du Y; Wang M; Wang X; Zhang W; Gong W; Ling C; Wu S; Hu R
Mol Biol Rep; 2011 Feb; 38(2):1145-50. PubMed ID: 20625834
[TBL] [Abstract][Full Text] [Related]
13. FTO, GCKR, CDKAL1 and CDKN2A/B gene polymorphisms and the risk of gestational diabetes mellitus: a meta-analysis.
Guo F; Long W; Zhou W; Zhang B; Liu J; Yu B
Arch Gynecol Obstet; 2018 Oct; 298(4):705-715. PubMed ID: 30074065
[TBL] [Abstract][Full Text] [Related]
14. GCKR polymorphism influences liver fat content in patients with type 2 diabetes.
Petit JM; Masson D; Guiu B; Rollot F; Duvillard L; Bouillet B; Brindisi MC; Buffier P; Hillon P; Cercueil JP; Verges B
Acta Diabetol; 2016 Apr; 53(2):237-42. PubMed ID: 25976242
[TBL] [Abstract][Full Text] [Related]
15. A modified response of NAFLD patients with non-significant fibrosis in nutritional counseling according to GCKR rs1260326.
Kaliora AC; Kalafati IP; Gioxari A; Diolintzi A; Kokkinos A; Dedoussis GV
Eur J Nutr; 2018 Sep; 57(6):2227-2235. PubMed ID: 28695325
[TBL] [Abstract][Full Text] [Related]
16. Associations between Methylenetetrahydrofolate Reductase (MTHFR) Polymorphisms and Non-Alcoholic Fatty Liver Disease (NAFLD) Risk: A Meta-Analysis.
Sun MY; Zhang L; Shi SL; Lin JN
PLoS One; 2016; 11(4):e0154337. PubMed ID: 27128842
[TBL] [Abstract][Full Text] [Related]
17. Association of GCKR and MBOAT7 genetic polymorphisms with non-alcoholic fatty liver disease.
Chavan SU; Rathi P; Mandot A
Clin Exp Hepatol; 2024 Mar; 10(1):39-46. PubMed ID: 38765903
[TBL] [Abstract][Full Text] [Related]
18. Associations of apolipoprotein A5 (APOA5), glucokinase (GCK) and glucokinase regulatory protein (GCKR) polymorphisms and lifestyle factors with the risk of dyslipidemia and dysglycemia in Japanese - a cross-sectional data from the J-MICC Study.
Hishida A; Morita E; Naito M; Okada R; Wakai K; Matsuo K; Nakamura K; Takashima N; Suzuki S; Takezaki T; Mikami H; Ohnaka K; Watanabe Y; Uemura H; Kubo M; Tanaka H; Hamajima N
Endocr J; 2012; 59(7):589-99. PubMed ID: 22517333
[TBL] [Abstract][Full Text] [Related]
19. Association between ADIPOQ G276T and C11377G polymorphisms and the risk of non-alcoholic fatty liver disease: An updated meta-analysis.
Liu M; Liu S; Shang M; Liu X; Wang Y; Li Q; Mambiya M; Yang L; Zhang Q; Zhang K; Nie F; Zeng F; Liu W
Mol Genet Genomic Med; 2019 May; 7(5):e624. PubMed ID: 30838812
[TBL] [Abstract][Full Text] [Related]
20. Contribution of a genetic risk score to clinical prediction of hepatic steatosis in obese children and adolescents.
Zusi C; Mantovani A; Olivieri F; Morandi A; Corradi M; Miraglia Del Giudice E; Dauriz M; Valenti L; Byrne CD; Targher G; Maffeis C
Dig Liver Dis; 2019 Nov; 51(11):1586-1592. PubMed ID: 31255630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
